USA
Analytical Standards
Controlled Research Environment
Research Product
BPC-157 / TB-500
1. Product Overview
BPC-157 / TB-500 is a research peptide blend combining BPC-157 and TB-500 in a standardized formulation. This combination has attracted scientific interest in studies involving cellular signaling, tissue remodeling, angiogenesis, extracellular matrix regulation, and regenerative biological pathways. Ongoing research continues to explore the interaction of these peptides with various cellular response mechanisms and tissue-related biological processes. The blend is supplied as a lyophilized research peptide formulation and undergoes analytical testing to verify identity, purity, and consistency.
Manufactured in a controlled research environment, this product is intended exclusively for laboratory and scientific research applications.
2. Specifications
| Product Name | BPC-157 / TB-500 | Testing Method | HPLC |
|---|---|---|---|
| Synonym | Body Protection Compound-157 / Thymosin Beta-4 Fragment | Storage Condition | 2-8C |
| Format | Lyophilized Powder | Shelf Life | 24 Months |
| Content | 10 mg per vial | Manufacturing Standard | GMP Standard Research Environment |
| Purity | >=99% HPLC | Country of Origin | USA |
| Appearance | White to Off White Lyophilized Powder | Intended Use | Research Use Only |
3. Research Summary
BPC-157 / TB-500 is a research peptide blend combining BPC-157 and TB-500 in a standardized formulation. This combination has attracted scientific interest in studies involving cellular signaling, tissue remodeling, angiogenesis, extracellular matrix regulation, cellular migration, and regenerative biological pathways.
Research involving BPC-157 has explored its interaction with tissue response mechanisms, vascular biology, and peptide-mediated cellular signaling, while TB-500 has been investigated for its role in cellular migration, cytoskeletal organization, and tissue remodeling processes. Ongoing laboratory studies continue to evaluate the combined interaction of these peptides in various regenerative and cellular research models.
4. Scientific References
- Sikiric P, Seiwerth S, Rucman R, et al. Stable gastric pentadecapeptide BPC-157: Novel therapy in gastrointestinal tract and beyond. Current Pharmaceutical Design. 2011;17(16):1612-1632.
- Sikiric P, Hahm KB, Blagaic AB, et al. Stable gastric pentadecapeptide BPC-157 and wound healing. Frontiers in Pharmacology. 2020;11:627533.
- Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JHS. The promoting effect of pentadecapeptide BPC-157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of Applied Physiology. 2011;110(3):774-780.
- Goldstein AL, Hannappel E, Kleinman HK. Thymosin β4: Actin-sequestering protein moonlights to repair injured tissues. Trends in Molecular Medicine. 2005;11(9):421-429.
- Malinda KM, Goldstein AL, Kleinman HK. Thymosin beta 4 stimulates directional migration of human umbilical vein endothelial cells. FASEB Journal. 1997;11(7):474-481.
Disclaimer: This product is intended strictly for research use only. It is not intended for human consumption, clinical application, diagnostic procedures, therapeutic use, veterinary use, or household use. The information provided is for scientific and educational reference purposes only and should not be interpreted as medical advice, treatment guidance, or usage instructions. This product should be handled only by qualified professionals trained in laboratory practices. Purchasers and end users are solely responsible for ensuring compliance with all applicable laws, regulations, and institutional requirements governing the purchase, storage, handling, and use of research materials.
